Beam Therapeutics

Beam TherapeuticsBeam Therapeutics
Beam Therapeutics

Beam Therapeutics

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Website
DR 0.12017InactiveCambridge, United States
Rate
Advertise here

About

Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines based on its proprietary base editing technology. This technology allows for precise, single-base changes in DNA and RNA without cutting the double helix, offering a new approach to treating genetic diseases by correcting specific mutations.
Frequently asked

What does Beam Therapeutics do?

Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines based on its proprietary base editing technology. This technology allows for precise, single-base changes in DNA and RNA without cutting the double helix, offering a new approach to treating genetic diseases by correcting specific mutations.

What is Beam Therapeutics's valuation?

StartupHub estimates Beam Therapeutics's effective valuation at $870.3M (range $587.5M to $1.4B, 10% confidence), based on comparable companies in the sector.

How much funding has Beam Therapeutics raised?

Beam Therapeutics has raised a total of $235M in funding. The most recent round on record is Series C.

Where is Beam Therapeutics headquartered?

Beam Therapeutics is headquartered in Cambridge, United States.

When was Beam Therapeutics founded?

Beam Therapeutics was founded in 2017.

What industry does Beam Therapeutics operate in?

Beam Therapeutics operates in Workflows, Biotech, MedTech, Genomics, Drug Discovery, Genetic Medicine.

What is Beam Therapeutics's current status?

Beam Therapeutics's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.